title: Controversial role of bevacizumab in the development of venous thromboembolic events.
authors.forename: Sanjaykumar
authors.initials: S
authors.lastname: Hapani
authors.forename: Shenhong
authors.initials: S
authors.lastname: Wu
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*; D054556:Venous Thromboembolism / Q000453:epidemiology*
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D042461:Vascular Endothelial Growth Factor A